BiotechTube
Home/Sinntaxis/Christine Widstrand
CW

Christine Widstrand

Chairman of the Board

Sinntaxis

Therapeutic Areas

NeurologyStroke

Sinntaxis Pipeline

DrugIndicationPhase
mGluR5 NAM for Stroke Recovery (dipraglurant via Addex)Recovery of brain function after stroke/brain injuryPhase 2 Ready

Leadership Team at Sinntaxis

TW
Tadeusz Wieloch
CEO, Founder
LÖ
Lars Öhman
Board Member
View full Sinntaxis profile